A randomized controlled trial investigating experiential virtual reality communication on prudent antibiotic use

IF 12.4 1区医学 Q1 HEALTH CARE SCIENCES & SERVICES

NPJ Digital Medicine Pub Date : 2024-09-12 DOI:10.1038/s41746-024-01240-3

Adéla Plechatá, Guido Makransky, Robert Böhm

{"title":"A randomized controlled trial investigating experiential virtual reality communication on prudent antibiotic use","authors":"Adéla Plechatá, Guido Makransky, Robert Böhm","doi":"10.1038/s41746-024-01240-3","DOIUrl":null,"url":null,"abstract":"Antimicrobial resistance (AMR) is a global health threat. This randomized controlled trial evaluates the impact of experiential virtual reality (VR) versus information provision via VR or leaflet on prudent antibiotic use. A total of 249 (239 analyzed) participants were randomized into three conditions: VR Information + Experience, VR Information, or Leaflet Information. All participants received AMR information, while those in the VR Information + Experience condition additionally engaged in a game, making treatment decisions for their virtual avatar’s infection. Participants in the VR Information + Experience condition showed a significant increase in prudent use intentions from baseline (d = 1.48). This increase was significantly larger compared to the VR Information (d = 0.50) and Leaflet Information (d = 0.79) conditions. The increase in intentions from baseline remained significant at follow-up in the VR Information + Experience condition (d = 1.25). Experiential VR communication shows promise for promoting prudent antibiotics use.","PeriodicalId":19349,"journal":{"name":"NPJ Digital Medicine","volume":" ","pages":"1-8"},"PeriodicalIF":12.4000,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.com/articles/s41746-024-01240-3.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Digital Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.nature.com/articles/s41746-024-01240-3","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}

引用次数: 0

Abstract

Antimicrobial resistance (AMR) is a global health threat. This randomized controlled trial evaluates the impact of experiential virtual reality (VR) versus information provision via VR or leaflet on prudent antibiotic use. A total of 249 (239 analyzed) participants were randomized into three conditions: VR Information + Experience, VR Information, or Leaflet Information. All participants received AMR information, while those in the VR Information + Experience condition additionally engaged in a game, making treatment decisions for their virtual avatar’s infection. Participants in the VR Information + Experience condition showed a significant increase in prudent use intentions from baseline (d = 1.48). This increase was significantly larger compared to the VR Information (d = 0.50) and Leaflet Information (d = 0.79) conditions. The increase in intentions from baseline remained significant at follow-up in the VR Information + Experience condition (d = 1.25). Experiential VR communication shows promise for promoting prudent antibiotics use.

Abstract Image

查看原文本刊更多论文

一项随机对照试验，调查虚拟现实体验式传播对谨慎使用抗生素的影响

抗生素耐药性（AMR）是一个全球性的健康威胁。这项随机对照试验评估了体验式虚拟现实（VR）与通过 VR 或传单提供信息对谨慎使用抗生素的影响。共有 249 名参与者（分析了 239 人）被随机分为三种情况：VR信息+体验、VR信息或宣传单信息。所有参与者都收到了 AMR 信息，而 VR 信息+体验条件下的参与者还参与了一个游戏，为他们虚拟化身的感染做出治疗决定。与基线相比，"VR 信息+体验 "条件下的参与者的谨慎使用意愿有了显著提高（d = 1.48）。与 VR 信息（d = 0.50）和传单信息（d = 0.79）条件相比，这一增幅明显更大。在 "VR 信息 + 体验 "条件下（d = 1.25），与基线相比，使用意向的增加仍然显著。体验式 VR 传播有望促进抗生素的谨慎使用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

NPJ Digital Medicine Multiple-

CiteScore

25.10

自引率

3.30%

发文量

170

审稿时长

15 weeks

期刊介绍： npj Digital Medicine is an online open-access journal that focuses on publishing peer-reviewed research in the field of digital medicine. The journal covers various aspects of digital medicine, including the application and implementation of digital and mobile technologies in clinical settings, virtual healthcare, and the use of artificial intelligence and informatics. The primary goal of the journal is to support innovation and the advancement of healthcare through the integration of new digital and mobile technologies. When determining if a manuscript is suitable for publication, the journal considers four important criteria: novelty, clinical relevance, scientific rigor, and digital innovation.